Trial Profile
A Multicenter Randomized Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Raltitrexed (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 17 Aug 2015 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (verified October 2012).
- 21 Dec 2012 New trial record